CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(09): E893-E898
DOI: 10.1055/a-2153-7094
Original article

ERCP in patients over 90 years old: Safety and efficacy comparison with a younger cohort

Ana E Colmenero Gargari
1   Family Medicine, Bella Vista Hospital, Mayaguez, Puerto Rico (Ringgold ID: RIN36641)
,
Fernando E Melgar Somoza
1   Family Medicine, Bella Vista Hospital, Mayaguez, Puerto Rico (Ringgold ID: RIN36641)
,
Jorge Vera
1   Family Medicine, Bella Vista Hospital, Mayaguez, Puerto Rico (Ringgold ID: RIN36641)
,
2   Division of Gastroenterology, Bella Vista Hospital, Mayaguez, Puerto Rico (Ringgold ID: RIN36641)
› Institutsangaben

Abstract

Background and study aims As life expectancy increases worldwide, so does the prevalence of biliary tract and pancreatic disorders, resulting in rising demand for invasive procedures such as endoscopic retrograde cholangiopancreatography (ERCP) in the elderly. Few studies have assessed the safety of ERCP in patients 90 years and older, particularly among the Hispanic population. The primary aim of this study was to determine the technical success and adverse events (AEs) associated with ERCP in patients 90 years of age or older in comparison to a younger cohort of patients.

Patients and methods A retrospective analysis of all ERCPs done at our institution from 2012 to 2018 was performed. Three hundred ERCPs in patients < 90 years old and all 28 ERCPs done in patients ≥ 90 years old were included in the analysis.

Results ERCPs were successfully completed in 96.4% of patients > 90 years old and 96.3% of the < 90-year-old cohort (realtive risk [RR] 1.00, confidence interval 0.92-1.07). There was no difference in the rate of periprocedural AEs. Post-ERCP AEs occurred in 7.1% and 3.0% in patients aged < 90 and > 90 years, respectively (RR 2.38, 0.54-10.48). No deaths were directly attributed to the procedure; however, inpatient mortality was higher in the group aged > 90 years.

Conclusions ERCP is safe and effective in nonagenarian patients, and advanced age should not be considered an independent risk factor for AEs nor a contraindication for the procedure.



Publikationsverlauf

Eingereicht: 29. Juni 2022

Angenommen nach Revision: 21. Juli 2023

Accepted Manuscript online:
14. August 2023

Artikel online veröffentlicht:
06. Oktober 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany